Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice
The FASEB Journal · 2026
DOI: 10.1096/fj.202603175r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Soyoung Park und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Retinal Neovascularization, Receptors, LDL, Unfolded Protein Response, Signal Transduction. Die Arbeit nennt 67 Literaturangaben. Gefördert von: National Institutes of Health (NIH), VA, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Pathological neovascularization drives blinding retinal diseases, including diabetic retinopathy, retinopathy of prematurity, and neovascular age‐related macular degeneration. Endoplasmic reticulum (ER) stress and unfolded protein response (UPR) signaling are key mechanisms underlying neovascularization. Mice lacking the UPR regulator Activating Transcription Factor 6 (ATF6) show normal retinal vasculature yet are resistant to pathologic neovascularization, suggesting that ATF6 inhibition may mitigate retinal damage and vision loss from aberrant retinal angiogenesis. We tested Ceapin‐A7, a selective ATF6 inhibitor, in Vldlr −/− mice, a genetic model of retinal neovascularization. Intravitreal Ceapin‐A7 reduced ectopic vascular projections into the outer retina and significantly increased scotopic b‐wave amplitude, while a‐wave and photopic responses showed no significant difference between groups. Single‐nucleus RNA sequencing revealed suppressed ATF6/UPR gene programs and angiogenic pathways in retinal endothelial cells and reduced Müller cell gliosis. These findings demonstrate that pharmacologic ATF6 inhibition mitigates retinal neovascularization in Vldlr −/− mice and identifies ATF6/UPR as a therapeutic target for neovascular retinal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University, Stanford, California, USA.
- Department of Ophthalmology, Stanford University, Stanford, California, USA.
- VA Palo Alto Healthcare System, Palo Alto, California, USA.
Förderung
- National Institutes of Health (NIH)
- VA
- U.S. Department of Veterans Affairs
Zitieren
APA
Park, S., Galdamez, A., Temme, W., Bradley, A., Le, M., Chea, L., Stevenson, E., Gradilla, Y., Lee, E. J., & Lin, J. H. (2026). Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice. The FASEB Journal. https://doi.org/10.1096/fj.202603175r
Vancouver
Park S, Galdamez A, Temme W, Bradley A, Le M, Chea L, et al. Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice. The FASEB Journal. 2026. doi:10.1096/fj.202603175r
BibTeX
@article{Park2026,
author = {Park, Soyoung and Galdamez, Angela and Temme, William and Bradley, Allyssa and Le, Masako and Chea, Leon and Stevenson, Ethan and Gradilla, Yudith and Lee, Eun-Jin and Lin, Jonathan H},
title = {Ceapin‐ A7 Suppresses UPR Signaling and Mitigates Retinal Neovascularization in Vldlr −/− Mice},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202603175r}
}
EUVIMED